Dark | Light
# acasunlimab

Acasunlimab sees a surge in community interest with a 134% increase in engagements over [--] months, though recent 24-hour activity shows a dip. Creator activity is also up significantly, indicating a growing buzz around this bispecific antibody.

### About acasunlimab
Acasunlimab is a bispecific antibody developed for cancer immunotherapy.  

### Insights
- acasunlimab engagements is up 33.96% from the previous week.

### Engagements: [--] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:acasunlimab/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/acasunlimab/time-series/interactions.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [--] +34%  
[--] Month: [---] -97%  
[--] Months: [------] +151%  
[--] Year: [------] -56%  
1-Year High: [-----] on 2025-12-29  
1-Year Low: [--] on 2025-04-07  

Engagements by network (24h):
News: [--]
X: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:acasunlimab/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/acasunlimab/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] -27%  
[--] Month: [--] -38%  
[--] Months: [---] +445%  
[--] Year: [---] +15%  
1-Year High: [--] on 2025-09-25  
1-Year Low: [--] on 2025-02-15  

Mentions by network (24h):
News: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:acasunlimab/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/acasunlimab/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning acasunlimab in the last [--] hours which is down 17% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -20%  
[--] Month: [--] -29%  
[--] Months: [--] +380%  
[--] Year: [--] +13%  
1-Year High: [--] on 2025-12-30  
1-Year Low: [--] on 2025-02-15  
  
  
### Sentiment: %
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:acasunlimab/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/acasunlimab/time-series/sentiment.tsv)  
Current Value: %  
Daily Average: 82%  
[--] Week: 67% no change  
[--] Month: 67% -13%  
[--] Months: 67% +7%  
[--] Year: 67% -33%  
1-Year High: 100% on 2025-10-07  
1-Year Low: 33% on 2025-10-03

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

acasunlimab

Acasunlimab sees a surge in community interest with a 134% increase in engagements over [--] months, though recent 24-hour activity shows a dip. Creator activity is also up significantly, indicating a growing buzz around this bispecific antibody.

About acasunlimab

Acasunlimab is a bispecific antibody developed for cancer immunotherapy.

Insights

  • acasunlimab engagements is up 33.96% from the previous week.

Engagements: [--] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [--] +34%
[--] Month: [---] -97%
[--] Months: [------] +151%
[--] Year: [------] -56%
1-Year High: [-----] on 2025-12-29
1-Year Low: [--] on 2025-04-07

Engagements by network (24h): News: [--] X: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] -27%
[--] Month: [--] -38%
[--] Months: [---] +445%
[--] Year: [---] +15%
1-Year High: [--] on 2025-09-25
1-Year Low: [--] on 2025-02-15

Mentions by network (24h): News: [--] X: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning acasunlimab in the last [--] hours which is down 17% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -20%
[--] Month: [--] -29%
[--] Months: [--] +380%
[--] Year: [--] +13%
1-Year High: [--] on 2025-12-30
1-Year Low: [--] on 2025-02-15

Sentiment: %

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: 82%
[--] Week: 67% no change
[--] Month: 67% -13%
[--] Months: 67% +7%
[--] Year: 67% -33%
1-Year High: 100% on 2025-10-07
1-Year Low: 33% on 2025-10-03

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

acasunlimab
/topic/acasunlimab